Group One Trading, L.P. Immunome Inc. Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$11.7 - $16.51 $89,107 - $125,740	7,616 New	7,616 $111,000
Q1 2023 May 12, 2023	BUY	$3.26 - $5.69 $18,024 - $31,460	5,529 Added 254.09%	7,705 $38,000
Q4 2022 Feb 09, 2023	SELL	$2.21 - $5.0 $221 - $500	-100 Reduced 4.39%	2,176 $4,000
Q3 2022 Nov 09, 2022	BUY	$3.39 - $6.14 $7,552 - $13,679	2,228 Added 4641.67%	2,276 $10,000
Q2 2022 Aug 11, 2022	BUY	$2.24 - $5.79 $107 - $277	48 New	48 $0

125

45.4M

38.7K

2.05M

Ticker IMNM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,127,400
Market Cap $98.5M
Description
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.